Home » Bristol-Myers Sells Asia OTC Business for $310 Million
Bristol-Myers Sells Asia OTC Business for $310 Million
Bristol-Myers Squibb Co. said it will sell most of its Asia-Pacific over the counter drug business to Taisho Pharmaceutical Co. for $310 million.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May